Is Mycoplasma genitalium a sexually transmitted infection (STI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Mycoplasma genitalium an STI?

Yes, Mycoplasma genitalium is definitively a sexually transmitted infection (STI). 1, 2

Transmission and Recognition

M. genitalium is transmitted through sexual contact and is now well-established as an emerging STI that has gained recognition over the past three decades 3, 4. The bacterium spreads through:

  • Vaginal intercourse - the primary transmission route in heterosexual populations
  • Anal intercourse - particularly common among men who have sex with men (MSM)
  • Sexual contact with infected partners 2

While M. genitalium was first isolated in 1981, its classification as a sexually transmitted infection was not firmly established until the early 2000s 2. It is now recognized globally as a frequent cause of urogenital infections transmitted through sexual activity.

Clinical Significance as an STI

M. genitalium causes several sexually transmitted syndromes:

In males:

  • Urethritis (both gonococcal and non-gonococcal) 5, 1
  • Epididymitis 1
  • Proctitis 1
  • Often asymptomatic, making detection challenging 4

In females:

  • Cervicitis 1, 4
  • Pelvic inflammatory disease (PID) 1, 4
  • Potential complications including infertility and adverse pregnancy outcomes 1, 3
  • May present with nonspecific symptoms like dysuria, vaginal discharge, or pelvic pain 4

Treatment Considerations

The CDC guidelines specifically address M. genitalium in the context of STI treatment, noting that infections with M. genitalium respond better to azithromycin than doxycycline 5. Current recommendations include two-step treatment with doxycycline followed by either azithromycin or moxifloxacin, with resistance-guided therapy preferred when available 1.

Critical caveat: M. genitalium has developed significant antimicrobial resistance, earning it the designation as a "new STI superbug" in media reports 3. This makes it a particularly challenging STI to manage clinically 6.

Testing Recommendations

Testing should be targeted rather than universal 1:

  • Persistent male urethritis
  • Cervicitis and proctitis
  • Pelvic inflammatory disease (consider testing)
  • Sexual contacts of patients with confirmed M. genitalium
  • Not recommended for asymptomatic patients, including pregnant individuals without exposure history 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.